Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,080 | -26,733 | N/A | -105,691 | -74,815 |
| Depreciation Amortization | 1,020 | 541 | N/A | 1,779 | 1,191 |
| Income taxes - deferred | N/A | N/A | N/A | -206 | -206 |
| Accounts receivable | N/A | N/A | N/A | 98 | 99 |
| Other Working Capital | 1,453 | -1,744 | N/A | 4,981 | 557 |
| Other Operating Activity | 5,404 | 1,352 | 0 | 8,773 | 5,592 |
| Operating Cash Flow | $-43,203 | $-26,584 | $N/A | $-90,266 | $-67,582 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -939 | -526 | N/A | -3,638 | -2,660 |
| Investing Cash Flow | $-939 | $-526 | $N/A | $-3,638 | $-2,660 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,328 | 25,245 | N/A | N/A | 105 |
| Common Stock Repurchased | 110 | N/A | N/A | 104 | N/A |
| Financing Cash Flow | $27,438 | $25,245 | $N/A | $104 | $105 |
| Exchange Rate Effect | -11,072 | -2,718 | N/A | 36 | 4,716 |
| Beginning Cash Position | 119,063 | 119,063 | N/A | 231,576 | 231,576 |
| End Cash Position | 91,287 | 114,480 | N/A | 137,812 | 166,155 |
| Net Cash Flow | $-27,776 | $-4,583 | $N/A | $-93,764 | $-65,421 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,203 | -26,584 | N/A | -90,266 | -67,582 |
| Capital Expenditure | -939 | -526 | N/A | -3,638 | -2,660 |
| Free Cash Flow | -44,142 | -27,110 | 0 | -93,904 | -70,242 |